Frederik Groenewegen
Managing Director @ 415 Capital
Munich, Germany
Frederik Groenewegen is a Series B investor at 415 Capital in Munich focused on Medical and Medical Device. Frederik Groenewegen
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Frederik Groenewegen invests in
Stages Frederik Groenewegen invests in
Countries Frederik Groenewegen invests in
Investment Focus
Industry
- Medical 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CorFlow Therapeutics
|
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients. | $48.5M / Series B / Sep 10, 2024 |
Co-Investors
Broadview Ventures
1 deal together
KOFA Healthcare
1 deal together
Laerdal Million Lives Fund
1 deal together
Mérieux Equity Partners
1 deal together
Mérieux Equity Partners
1 deal together
M&L Healthcare Investments
1 deal together
About 415 Capital
415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel.They primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcaresystem.We are investors AND entrepreneurs: As investors, They have funded 45 MedTech companies in the past 28 years. As entrepreneurs, They have founded, built, and exited several successful European MedTech distribution companies.
415 Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Azin Parhizgar
Senior Venture Partner
|
|||
Frank Groenewegen
Managing Director
|
|||
|
Frederik Groenewegen
Managing Director
|
|||
Ruben Osnabrugge
Partner
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Frederik Groenewegen invest in?
Frederik Groenewegen invests primarily in Medical and Medical Device startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Frederik Groenewegen last invest?
The most recent investment recorded for Frederik Groenewegen closed in Sep 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
